Capital Markets Trading Uk LLP Abb Vie Inc. Transaction History

Capital Markets Trading Uk LLP

$7 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$107.43 - $135.93 $3.61 Million - $4.57 Million	-33,624 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $1.33 Million - $1.51 Million	12,520 Added 59.33%	33,624 $3.66 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $79,328 - $88,376	754 Added 3.71%	21,104 $2.38 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $839,780 - $924,497	8,209 Added 67.61%	20,350 $2.2 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $224,969 - $303,732	-2,795 Reduced 18.71%	12,141 $1.3 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $1.69 Million - $1.98 Million	-19,626 Reduced 56.78%	14,936 $1.26 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $902,230 - $1.21 Million	12,297 Added 55.23%	34,562 $3.39 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $810,507 - $1.23 Million	12,566 Added 129.56%	22,265 $1.7 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $193,669 - $242,321	2,685 Added 38.28%	9,699 $859,000
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $693,031 - $833,222	-11,004 Reduced 61.07%	7,014 $531,000
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $669,417 - $855,672	10,189 Added 130.14%	18,018 $1.31 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $603,929 - $710,794	7,829 New	7,829 $631,000
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $1.35 Million - $1.66 Million	-17,317 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $1.54 Million - $1.71 Million	17,317 New	17,317 $1.64 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $395,480 - $467,943	-4,405 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $405,304 - $542,740	4,405 New	4,405 $417,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Markets Trading Uk LLP, based on Form 13F filings with the SEC.

News

Stay updated on Capital Markets Trading Uk LLP with notifications on news.

Account